SCHEMBL39504

SCHEMBL39504

CC(C)OB(O)OC(C)(C)C(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17259105 0.78
SCHEMBL12675479 0.78
SCHEMBL17821283 0.73
SCHEMBL5837790 0.71
SCHEMBL69943 0.71
SCHEMBL362862 0.70
SCHEMBL194317 0.69 THRB (0.30)
Boric Acid SCHEMBL362864 0.69
Boric Acid SCHEMBL25366209 0.68
SCHEMBL17821297 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11878989-B2 Method for preparing L-erythrobiopterin compound SHANGHAI FOREFRONT PHARMA CO., LTD. (CN) 2024-01-23 US claimed
US-20220298178-A1 METHOD FOR PREPARING L-ERYTHROBIOPTERIN COMPOUND SHANGHAI FOREFRONT PHARMA CO., LTD. (CN) 2022-09-22 US claimed
EP-4019523-A1 METHOD FOR PREPARING L-ERYTHROBIOPTERIN COMPOUND Shanghai Forefront Pharma Co., Ltd. (CN) 2022-06-29 EP claimed
CN-110204733-B Alpha-mannose modified donor-receptor type biopolymer material and preparation method and application thereof 长安大学 2021-07-02 CN claimed
CN-108484653-B Preparation method of thiophene borate 甘肃农业大学 2021-02-05 CN claimed
WO-2013112493-A1 [N]CYCLOPARAPHENYLENES (CPP), [N]MACROCYCLE INTERMEDIATES AND METHODS OF MAKING SAME TRUSTEES OF BOSTON UNIVERSITY (US) 2013-08-01 WO claimed
US-12595263-B2 Pyrazolopyrimidine compound used as ATR kinase inhibitor BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) 2026-04-07 US disclosed
US-12583825-B2 Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer Redona Therapeutics, Inc. (US) 2026-03-24 US disclosed
US-20260078131-A1 PYRROLO-PYRIDAZINE INHIBITORS OF JAK2 AJAX THERAPEUTICS INC (US) 2026-03-19 US disclosed
US-20260013393-A1 COMPOUND, LIGHT EMITTING MATERIAL AND LIGHT EMITTING ELEMENT KYULUX INC (JP) 2026-01-08 US disclosed
US-20250388565-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2025-12-25 US disclosed
EP-4644393-A1 WRN INHIBITOR Suzhou Puhe Biopharma Co., Ltd. (CN) 2025-11-05 EP disclosed
EP-4624468-A1 COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2025-10-01 EP disclosed
WO-2013112493-A1 [N]CYCLOPARAPHENYLENES (CPP), [N]MACROCYCLE INTERMEDIATES AND METHODS OF MAKING SAME TRUSTEES OF BOSTON UNIVERSITY (US) 2013-08-01 WO disclosed
WO-2013008951-A1 ORGANIC DYE, DYE-SENSITIZED METAL OXIDE SEMICONDUCTOR ELECTRODE AND DYE-SENSITIZED SOLAR CELL NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2013-01-17 WO disclosed
WO-2012125832-A2 ANTIMICROBIAL AGENTS RIB-X PHARMACEUTICALS, INC. (US) 2012-09-20 WO disclosed
WO-2011161417-A1 ORGANIC LIGHT-EMITTING MATERIAL DEVICE AND METHOD CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-12-29 WO disclosed
EP-2382281-A1 BLUE EMITTER WITH HIGH EFFICIENCY BASED ON IMIDAZO [1,2-f]¨PHENANTHRIDINE IRIDIUM COMPLEXES Universal Display Corporation (US) 2011-11-02 EP disclosed
US-20100148663-A1 Blue Emitter with High Efficiency Based on Imidazo[1,2-f] Phenanthridine Iridium Complexes UNIVERSAL DISPLAY CORPORATION (US) 2010-06-17 US disclosed
WO-2010068876-A1 BLUE EMITTER WITH HIGH EFFICIENCY BASED ON IMIDAZO [1,2-f] PHENANTHRIDINE IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2010-06-17 WO disclosed